Cardiac calcium handling on trial: editorial
Targeting abnormal calcium (Ca)2+ handling in ventricular cardiomyocytes emerged as a new paradigm for human heart failure (HF) therapy.1 Cardiomyocytes come with an extensive Ca2+ signaling toolkit consisting of various Ca2+ transporters, Ca2+ channels, Ca2+ buffer, and sensor proteins. Organized i...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 2, 2014
|
| In: |
Circulation research
Year: 2014, Jahrgang: 114, Heft: 1, Pages: 12-14 |
| ISSN: | 1524-4571 |
| DOI: | 10.1161/CIRCRESAHA.113.302748 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1161/CIRCRESAHA.113.302748 Verlag, Volltext: http://circres.ahajournals.org/content/114/1/12 
|
| Verfasserangaben: | Sven T. Pleger, Philip Raake, Hugo A. Katus, Patrick Most |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1551262088 | ||
| 003 | DE-627 | ||
| 005 | 20220813112010.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 161223s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCRESAHA.113.302748 |2 doi | |
| 035 | |a (DE-627)1551262088 | ||
| 035 | |a (DE-576)481262083 | ||
| 035 | |a (DE-599)BSZ481262083 | ||
| 035 | |a (OCoLC)1340948336 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pleger, Sven Torsten |d 1973- |e VerfasserIn |0 (DE-588)129962473 |0 (DE-627)484985221 |0 (DE-576)297924001 |4 aut | |
| 245 | 1 | 0 | |a Cardiac calcium handling on trial |b editorial |c Sven T. Pleger, Philip Raake, Hugo A. Katus, Patrick Most |
| 264 | 1 | |c January 2, 2014 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.12.2016 | ||
| 520 | |a Targeting abnormal calcium (Ca)2+ handling in ventricular cardiomyocytes emerged as a new paradigm for human heart failure (HF) therapy.1 Cardiomyocytes come with an extensive Ca2+ signaling toolkit consisting of various Ca2+ transporters, Ca2+ channels, Ca2+ buffer, and sensor proteins. Organized into self-contained signaling modules in which Ca2+ signaling functions within highly localized environments, the cardiac Ca2+ signalosome delivers dynamic signals with different spatial and temporal properties that relay compartmentalized Ca2+ oscillations into specific cellular functions.2 As a result, Ca2+ governs not only the cardiomyocyte contractile cycle, but also concurrently control transcription and muscle growth, electric excitability, cell survival, and energy metabolism.3 Article, see p 101. Key components of the cardiac Ca2+ signalosome remodel as a molecular hallmark in HF: loss of sarco(endo)plasmic reticulum ATPase 2a (SERCA2a) expression surfaced as 1 critical abnormality in experimental HF and human failing myocardium. The defect alone is sufficient to disable various Ca2+-dependent homeostatic mechanisms that drive further deterioration of cardiac function and structure after a primary insult, such as myocardial infarction.1 Translational studies, particularly in human-relevant large animal models, have successfully used recombinant adeno-associated viral (rAAV) vectors for cardiac- targeted delivery of therapeutically formulated synthetic SERCA2a DNA that resulted in safe and long-term restoration of cardiac function and reversal of structural, electric, and metabolic remodeling in experimental HF.4 Hence, targeting defective components of the cardiomyocyte Ca2+ signalosome in HF might bear therapeutic benefits beyond sole improvement of cardiac contractile performance (Figure). Figure. Calcium (Ca)2+ regulation of cardiomyocyte function is not limited to contractile performance but extends to control over nuclear transcription, electric activity, cell survival, and energy metabolism . … | ||
| 650 | 4 | |a calcium signaling | |
| 650 | 4 | |a Editorials | |
| 650 | 4 | |a genetic therapy | |
| 650 | 4 | |a heart failure | |
| 700 | 1 | |a Raake, Philip |d 1975- |e VerfasserIn |0 (DE-588)129151246 |0 (DE-627)390021725 |0 (DE-576)297510568 |4 aut | |
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Most, Patrick |d 1969- |e VerfasserIn |0 (DE-588)124606431 |0 (DE-627)363440267 |0 (DE-576)29440919X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation research |d New York, NY : Assoc., 1953 |g 114(2014), 1, Seite 12-14 |h Online-Ressource |w (DE-627)266880126 |w (DE-600)1467838-X |w (DE-576)075145766 |x 1524-4571 |7 nnas |a Cardiac calcium handling on trial editorial |
| 773 | 1 | 8 | |g volume:114 |g year:2014 |g number:1 |g pages:12-14 |g extent:3 |a Cardiac calcium handling on trial editorial |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIRCRESAHA.113.302748 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://circres.ahajournals.org/content/114/1/12 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20161223 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 124606431 |a Most, Patrick |m 124606431:Most, Patrick |d 910000 |d 910100 |e 910000PM124606431 |e 910100PM124606431 |k 0/910000/ |k 1/910000/910100/ |p 4 |y j | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |e 910000PK108916618 |e 910100PK108916618 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 129151246 |a Raake, Philip |m 129151246:Raake, Philip |d 910000 |d 910100 |e 910000PR129151246 |e 910100PR129151246 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 129962473 |a Pleger, Sven Torsten |m 129962473:Pleger, Sven Torsten |d 910000 |d 910100 |e 910000PP129962473 |e 910100PP129962473 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1551262088 |e 2949486177 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Sven Torsten","role":"aut","display":"Pleger, Sven Torsten","family":"Pleger"},{"family":"Raake","display":"Raake, Philip","given":"Philip","role":"aut"},{"family":"Katus","display":"Katus, Hugo","given":"Hugo","role":"aut"},{"display":"Most, Patrick","family":"Most","role":"aut","given":"Patrick"}],"language":["eng"],"title":[{"subtitle":"editorial","title_sort":"Cardiac calcium handling on trial","title":"Cardiac calcium handling on trial"}],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"January 2, 2014"}],"note":["Gesehen am 23.12.2016"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"corporate":[{"role":"isb","display":"American Heart Association"}],"part":{"text":"114(2014), 1, Seite 12-14","issue":"1","year":"2014","pages":"12-14","volume":"114","extent":"3"},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Cardiac calcium handling on trial editorialCirculation research","origin":[{"publisherPlace":"New York, NY","publisher":"Assoc.","dateIssuedKey":"1953","dateIssuedDisp":"1953-"}],"note":["Gesehen am 09.08.2019"],"pubHistory":["1.1953 -"],"title":[{"title":"Circulation research","title_sort":"Circulation research","subtitle":"an official journal of the American Heart Association"}],"id":{"eki":["266880126"],"issn":["1524-4571"],"zdb":["1467838-X"]},"recId":"266880126","physDesc":[{"extent":"Online-Ressource"}]}],"recId":"1551262088","physDesc":[{"extent":"3 S."}],"name":{"displayForm":["Sven T. Pleger, Philip Raake, Hugo A. Katus, Patrick Most"]},"id":{"doi":["10.1161/CIRCRESAHA.113.302748"],"eki":["1551262088"]}} | ||
| SRT | |a PLEGERSVENCARDIACCAL2201 | ||